Read about research from the November 2023 ASCO Plenary Series, which explores emerging treatments for advanced myeloma and stomach and gastroesophageal junction cancers.
Research from the 2024 ASCO Gastrointestinal Cancers Symposium will highlight studies that explore treatment options for people with cancers of the gastrointestinal tract, such as colorectal cancer, esophageal cancer, liver cancer, and neuroendocrine tumors.
Cancer survivor William S. Laird shares what it was like being diagnosed with appendiceal cancer, how he navigated multiple cancer surgeries and recurrences, and how he’s learned to move forward while living with cancer indefinitely.
Read about 2 studies from the November 2023 ASCO Plenary Series, which explore emerging treatments for advanced cancers of the stomach and esophagus.
In this podcast, 2 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting about preventing melanoma recurrence and reducing cancer disparities.
The ASCO Annual Meeting is being held June 2 to 6, and here is some of the notable research that will be presented today. Topics include treatment for anemia related to myelodysplastic syndromes, pembrolizumab for advanced cervical cancer, surgery options for early pancreatic cancer, weight loss in breast cancer survivorship, the effect of Medicare expansion on racial disparities, and collaborating across borders to help children with leukemia.
Read research from the January 2023 session of the ASCO Plenary Series, which highlights a study evaluating a blood-based test to select treatment for advanced gastrointestinal stromal tumors (GISTs).
In this podcast, Dr. Frank Penedo interviews esophageal cancer survivor Rachael Kearney about her experience being diagnosed with cancer, how she coped with side effects from treatment, and her advice for sharing your cancer story.
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include targeted therapy for advanced hormone receptor-positive, HER2-negative breast cancer and using liquid biopsy to guide post-surgery treatment decisions for stage II colon cancer.
Read research from the February 2022 session of the ASCO Plenary Series, which highlights a study on daily aspirin to prevent breast cancer recurrence and another on using targeted therapy to treat advanced pancreatic cancer with a specific mutation.
